Bektas Murat Yalcin1, Tevfik Fikret Karahan2, Muhittin Ozcelik3, Fusun Artiran Igde1. 1. The Faculty of Medicine, Department of Family Medicine, Ondokuz Mayis University, Kurupelit, Samsun, Turkey (Dr Yalcin, Dr Igde) 2. Faculty of Education, Department of Psychological Counseling and Guidance, Ondokuz Mayis University, Kurupelit, Samsun, Turkey (Dr Karahan) 3. Social Sciences Institute, Ondokuz Mayis University, Kurupelit, Samsun, Turkey (Dr Ozcelik)
Abstract
PURPOSE: The purpose of the study is to investigate the effect of an emotional intelligence program on the health-related quality of life and well-being of individuals with type 2 diabetes. METHODS: The BarOn Emotional Intelligence Scale (EQ-I), WHO Well-Being Questionnaire (WHO-WBQ-22), WHO Quality of Life Measure (WHOQOL-Bref), and the Medical Outcomes Study 36-Item Health Survey (SF-36) were administered to 184 patients with type 2 diabetes who volunteered to participate. Thirty-six patients with the lowest test scores on the WHO-WBQ-22, WHOQOL-Bref, and SF-36 were randomized into study and control groups (18 patients each). A 12-week emotional intelligence program was administered to the study group. At the end of the program, scales were readministered to both groups and again at 3 and 6 months. RESULTS: There were no differences between the quality of life, well-being, and emotional intelligence levels of the study and control groups before the commencement of the program (P > .05). At the conclusion of the program, quality of life, well-being, and emotional intelligence levels of study group patients increased in comparison with those in the control group (P < .001). The positive effect of the program on study groups' quality of life, wellbeing, and emotional intelligence persisted at the 3- and 6-month follow-up. CONCLUSION: The emotional intelligence program may have positive effects on quality of life and well-being of individuals with type 2 diabetes.
RCT Entities:
PURPOSE: The purpose of the study is to investigate the effect of an emotional intelligence program on the health-related quality of life and well-being of individuals with type 2 diabetes. METHODS: The BarOn Emotional Intelligence Scale (EQ-I), WHO Well-Being Questionnaire (WHO-WBQ-22), WHO Quality of Life Measure (WHOQOL-Bref), and the Medical Outcomes Study 36-Item Health Survey (SF-36) were administered to 184 patients with type 2 diabetes who volunteered to participate. Thirty-six patients with the lowest test scores on the WHO-WBQ-22, WHOQOL-Bref, and SF-36 were randomized into study and control groups (18 patients each). A 12-week emotional intelligence program was administered to the study group. At the end of the program, scales were readministered to both groups and again at 3 and 6 months. RESULTS: There were no differences between the quality of life, well-being, and emotional intelligence levels of the study and control groups before the commencement of the program (P > .05). At the conclusion of the program, quality of life, well-being, and emotional intelligence levels of study group patients increased in comparison with those in the control group (P < .001). The positive effect of the program on study groups' quality of life, wellbeing, and emotional intelligence persisted at the 3- and 6-month follow-up. CONCLUSION: The emotional intelligence program may have positive effects on quality of life and well-being of individuals with type 2 diabetes.
Authors: Christina N Massey; Emily H Feig; Laura Duque-Serrano; Deborah Wexler; Judith Tedlie Moskowitz; Jeff C Huffman Journal: Diabetes Res Clin Pract Date: 2018-11-27 Impact factor: 5.602
Authors: Emil F Coccaro; Tina Drossos; David Kline; Sophie Lazarus; Joshua J Joseph; Mary de Groot Journal: Prim Care Diabetes Date: 2022-03-11 Impact factor: 2.567
Authors: Emil F Coccaro; Sophie Lazarus; Joshua Joseph; Kathline Wyne; Tina Drossos; Louis Phillipson; Mary de Groot Journal: Diabetes Care Date: 2020-11-10 Impact factor: 19.112